Is topiramate a potential therapeutic agent for cerebral hypoxic/ischemic injury?

Exp Neurol. 2007 Jan;203(1):5-7. doi: 10.1016/j.expneurol.2006.09.014. Epub 2006 Oct 27.

Authors

Ji Woong Choi¹, Won-Ki Kim

Affiliation

¹ Division of NanoSciences, Ewha Woman's University, 11-1, Daehyun-dong, Seodaemun-gu, Seoul 120-750, Republic of Korea.

PMID: 17070522
DOI: 10.1016/j.expneurol.2006.09.014

No abstract available

Publication types

Review
Comment

MeSH terms

Animals
Brain / blood supply
Brain / drug effects*
Brain / physiopathology
Cell Death / drug effects
Cell Death / physiology
Cerebral Infarction / drug therapy
Cerebral Infarction / physiopathology
Cerebral Infarction / prevention & control
Fructose / analogs & derivatives*
Fructose / pharmacology
Fructose / therapeutic use
Humans
Hypoxia-Ischemia, Brain / drug therapy*
Hypoxia-Ischemia, Brain / physiopathology
Nerve Degeneration / drug therapy
Nerve Degeneration / physiopathology
Nerve Degeneration / prevention & control
Neuroprotective Agents / pharmacology*
Neuroprotective Agents / therapeutic use
Neurotoxins / antagonists & inhibitors
Neurotoxins / metabolism
Receptors, Glutamate / drug effects
Receptors, Glutamate / metabolism
Topiramate

Substances

Neuroprotective Agents
Neurotoxins
Receptors, Glutamate
Topiramate
Fructose